Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityConstruction in ProgressCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred Stock LiabilitiesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Organogenesis Holdings (ORGO) Other Non-Current Assets (2017 - 2026)

Organogenesis Holdings has reported Other Non-Current Assets over the past 9 years, most recently at $9.2 million for Q4 2025.

  • For Q4 2025, Other Non-Current Assets rose 83.88% year-over-year to $9.2 million; the TTM value through Dec 2025 reached $9.2 million, up 83.88%, while the annual FY2025 figure was $9.2 million, 83.88% up from the prior year.
  • Other Non-Current Assets for Q4 2025 was $9.2 million at Organogenesis Holdings, down from $14.4 million in the prior quarter.
  • Over five years, Other Non-Current Assets peaked at $14.4 million in Q3 2025 and troughed at $605000.0 in Q2 2021.
  • A 5-year average of $4.1 million and a median of $1.6 million in 2021 define the central range for Other Non-Current Assets.
  • Biggest five-year swings in Other Non-Current Assets: fell 16.9% in 2021 and later soared 358.58% in 2024.
  • Year by year, Other Non-Current Assets stood at $1.5 million in 2021, then decreased by 1.11% to $1.5 million in 2022, then surged by 294.08% to $6.0 million in 2023, then dropped by 16.44% to $5.0 million in 2024, then surged by 83.88% to $9.2 million in 2025.
  • Business Quant data shows Other Non-Current Assets for ORGO at $9.2 million in Q4 2025, $14.4 million in Q3 2025, and $8.7 million in Q2 2025.